fluoxetine and naltrexone

fluoxetine has been researched along with naltrexone in 34 studies

Research

Studies (34)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.94)	18.7374
1990's	11 (32.35)	18.2507
2000's	8 (23.53)	29.6817
2010's	13 (38.24)	24.3611
2020's	1 (2.94)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Flood, JF; Morley, JE	1
Benjamin, E; Buot-Smith, T	1
Carrion, VG	1
Avanzini, P; Caccavari, R; Delsignore, R; Fertonani, G; Gerra, G; Lucchini, A; Rota-Graziosi, I; Zaimovic, A	1
Cavallaro, CA; Chattophadyay, S; Gardell, LR; Hubbell, CL; Reid, LD; Whalen, CA	1
Araluce, K; Calle, R; Fernádez de Corres, B; Gutiérrez-Fraile, M; Iraurgi, I; Jiménez-Lerma, JM; Landabaso, MA; Sanz, J	1
Barringer, TM; Cavallaro, CA; Hubbell, CL; Mendez, JJ; Pabello, NG; Reid, LD	1
Anton, RF	1
Blatt, SD; Botash, AS; Church, CC; Jean-Louis, F; Meguid, V; Siripornsawan, MP; Weinberger, HL	1
Neumeister, A; Winkler, A; Wöber-Bingöl, C	1
Farren, CK; O'Malley, SS	1
Harding, S; Juzytsch, W; Lê, AD; Poulos, CX; Shaham, Y; Watchus, J	1
Clark, E; Hamedi, M; Janowsky, DS; Mason, GA; Overstreet, DH; Rezvani, AH; Yang, Y	1
Brenneman, D; Crooke, J; Malatynska, E; Pinhasov, A; Rosenthal, D	1
Bespalov, AY; Burakov, AM; Didenko, TY; Egorova, VY; Grinenko, AY; Ivanova, EB; Krupitsky, EM; Masalov, DV; Neznanov, NG; O'Brien, CP; Romanova, TN; Tsoy, MV; Verbitskaya, EV; Woody, GE; Zvartau, EE	1
Greenwald, MK	1
Burnand, B; Nanchen, D; Peytremann-Bridevaux, I; Walther, MR; Willi, C	1
Platt, DM; Rowlett, JK; Rüedi-Bettschen, D; Spealman, RD	1
Bespalov, AIu; Burakov, AM; Didenko, TIu; Egorova, VIu; Grineneko, AIa; Ivanova, EB; Krupitskiĭ, EM; Masalov, DV; Neznanov, NG; O'Brien, C; Romanova, TN; Tsoĭ-Podosenin, MV; Verbitskaia, EV; Woody, D; Zvartau, EE	1
Belkız Güngör, B; Çetinay Aydın, P; Gülseren, L	1
Horishita, T; Inagaki, H; Kawasaki, T; Obara, G; Sata, T; Takahashi, K; Toyohira, Y; Tsutsui, M; Ueno, S; Yanagihara, N	1
Ayranci, G; Befort, K; Filliol, D; Gavériaux-Ruff, C; Kieffer, BL; Lalanne, L; Lutz, PE	1
Gupta, T; Jain, S; Nebhinani, N; Singhai, K; Suthar, N	1
Dhejne, C; Görts Öberg, K; Jokinen, J; Savard, J	1

Reviews

3 review(s) available for fluoxetine and naltrexone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions. Alcohol and alcoholism (Oxford, Oxfordshire). Supplement, 1996, Volume: 31, Issue:1 Topics: Alcoholism; Bromocriptine; Dopamine Agonists; Female; Fluoxetine; Humans; Male; Models, Psychological; Naltrexone; Narcotic Antagonists; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic	1996
Sudden infant death syndrome, child sexual abuse, and child development. Current opinion in pediatrics, 1999, Volume: 11, Issue:2 Topics: Autistic Disorder; Child; Child Abuse, Sexual; Child, Preschool; Condylomata Acuminata; Fluoxetine; Humans; Infant; Infant, Newborn; Naltrexone; Narcotic Antagonists; Papillomaviridae; Papillomavirus Infections; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sudden Infant Death	1999

Trials

5 trial(s) available for fluoxetine and naltrexone

Article	Year
Hostility in heroin abusers subtypes: fluoxetine and naltrexone treatment. Progress in neuro-psychopharmacology & biological psychiatry, 1995, Volume: 19, Issue:8 Topics: Adult; Aggression; Antidepressive Agents, Second-Generation; Fenfluramine; Fluoxetine; Heroin Dependence; Hostility; Humans; Male; Naltrexone; Narcotic Antagonists; Neurosecretory Systems; Psychiatric Status Rating Scales; Treatment Outcome	1995
A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts. Addiction (Abingdon, England), 1998, Volume: 93, Issue:5 Topics: Adult; Drug Therapy, Combination; Female; Fluoxetine; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors	1998
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. Journal of substance abuse treatment, 2006, Volume: 31, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Heroin; Heroin Dependence; HIV Infections; Humans; Male; Naltrexone; Narcotic Antagonists; Psychotherapy; Russia; Secondary Prevention; Substance Abuse, Intravenous; Substance Withdrawal Syndrome	2006
[Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:5 Pt 2 Topics: Adolescent; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Placebos; Remission Induction; Selective Serotonin Reuptake Inhibitors; Young Adult	2010
A randomised controlled trial of fluoxetine versus naltrexone in compulsive sexual behaviour disorder: presentation of the study protocol. BMJ open, 2022, 06-03, Volume: 12, Issue:6 Topics: Adult; Compulsive Behavior; Compulsive Personality Disorder; Fluoxetine; Humans; Naltrexone; Randomized Controlled Trials as Topic; Sexual Behavior; Treatment Outcome	2022

Other Studies

26 other study(ies) available for fluoxetine and naltrexone

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice. Life sciences, 1987, Nov-02, Volume: 41, Issue:18 Topics: Amphetamine; Animals; Appetite Depressants; Body Weight; Calcitonin; Dextroamphetamine; Drug Tolerance; Eating; Fluoxetine; Mice; Morphine; Naltrexone; Neurotransmitter Agents	1987
Naltrexone and fluoxetine in Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 1993, Volume: 32, Issue:4 Topics: Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoxetine; Humans; Male; Naltrexone; Prader-Willi Syndrome; Self-Injurious Behavior	1993
Naltrexone for the treatment of trichotillomania: a case report. Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:6 Topics: Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Trichotillomania	1995
Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcoholism, clinical and experimental research, 1997, Volume: 21, Issue:8 Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Fluoxetine; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors	1997
Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone. Pharmacology, biochemistry, and behavior, 1998, Volume: 61, Issue:2 Topics: Analysis of Variance; Animals; Brain; Calcium Channel Blockers; Cocaine-Related Disorders; Drug Therapy, Combination; Electric Stimulation; Fluoxetine; Isradipine; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Valproic Acid	1998
Addition of naltrexone to fluoxetine in the treatment of binge eating disorder. The American journal of psychiatry, 1999, Volume: 156, Issue:5 Topics: Adolescent; Bulimia; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors	1999
Occurrence and management of depression in the context of naltrexone treatment of alcoholism. The American journal of psychiatry, 1999, Volume: 156, Issue:8 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Comorbidity; Depressive Disorder; Diagnosis, Dual (Psychiatry); Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Taurine	1999
Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1999, Volume: 21, Issue:3 Topics: Alcohol Deterrents; Alcohol Drinking; Animals; Central Nervous System Depressants; Ethanol; Fluoxetine; Male; Naltrexone; Narcotic Antagonists; Rats; Self Administration; Stress, Physiological	1999
Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats. Alcohol and alcoholism (Oxford, Oxfordshire), 2000, Volume: 35, Issue:1 Topics: Alcohol Drinking; Animals; Drug Therapy, Combination; Fluoxetine; Naltrexone; Narcotic Antagonists; Nootropic Agents; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Thyrotropin-Releasing Hormone	2000
Reduction of Submissive Behavior Model for antidepressant drug activity testing: study using a video-tracking system. Behavioural pharmacology, 2005, Volume: 16, Issue:8 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Competitive Behavior; Dominance-Subordination; Feeding Behavior; Fluoxetine; Imipramine; Maprotiline; Mice; Naltrexone; Narcotic Antagonists; Rats	2005
Behavioral economic analysis of drug preference using multiple choice procedure data. Drug and alcohol dependence, 2008, Jan-11, Volume: 93, Issue:1-2 Topics: Choice Behavior; Economics; Fentanyl; Fluoxetine; Hallucinogens; Humans; Hydromorphone; Injections, Intramuscular; Methadone; Models, Psychological; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotics; Psychotropic Drugs; Recreation; Selective Serotonin Reuptake Inhibitors; Substance Abuse, Intravenous; Substance-Related Disorders	2008
[Preventing weight gain in smoking cessation: there is no miracle solution]. Revue medicale suisse, 2009, Aug-05, Volume: 5, Issue:212 Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Fluoxetine; Humans; Naltrexone; Narcotic Antagonists; Patient Education as Topic; Risk; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain	2009
Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms. Psychopharmacology, 2010, Volume: 210, Issue:2 Topics: Animals; Benzofurans; Citalopram; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Fluoxetine; Ligands; Naltrexone; Pyrrolidines; Receptors, Opioid, kappa; Saimiri; Selective Serotonin Reuptake Inhibitors; Self Administration; Serotonin; Serotonin 5-HT1 Receptor Agonists	2010
Naltrexone treatment of kleptomania: a case report. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2012,Winter, Volume: 23, Issue:4 Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Depressive Disorder; Diagnosis, Differential; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluoxetine; Humans; Naltrexone; Obsessive-Compulsive Disorder	2012
Pentazocine inhibits norepinephrine transporter function by reducing its surface expression in bovine adrenal medullary cells. Journal of pharmacological sciences, 2013, Volume: 121, Issue:2 Topics: Adrenal Medulla; Analgesics, Opioid; Animals; Cattle; Cell Line; Cell Membrane; Cells, Cultured; Ethylenediamines; Fluoxetine; Gene Expression; Humans; Naltrexone; Narcotic Antagonists; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pentazocine; Radionuclide Imaging	2013
Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence. Addiction biology, 2017, Volume: 22, Issue:4 Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Disease Models, Animal; Fluoxetine; Grooming; Heroin; Heroin Dependence; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Social Behavior; Time; Treatment Outcome	2017
Therapeutic challenges in comorbid obsessive compulsive disorder with substance use. Asian journal of psychiatry, 2018, Volume: 31 Topics: Adrenergic alpha-2 Receptor Agonists; Clonazepam; Clonidine; Combined Modality Therapy; Fluoxetine; GABA Modulators; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Relaxation Therapy; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders	2018